Trial Profile
A phase IIa clinical trial investigating ALX-101 in patients with mild to moderate atopic dermatitis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2017
Price :
$35
*
At a glance
- Drugs ALX 101 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- 08 Dec 2015 New trial record